Clarity HD high-resolution 3D imaging and Intelligent 2D imaging technology from Hologic Inc., based in Marlborough, Mass., have received PMA approval from FDA, and are now available on the 3Dimensions breast tomosynthesis system. With these innovations, the system now provides higher resolution 3D images for radiologists, enhanced workflow for technologists, and a more comfortable mammography experience, with low-dose options, for patients.

“The passion that fueled our efforts to establish the Genius exam as the standard of care continues to drive us forward as we develop bold and innovative technologies optimized for superior performance for a diverse population of women,” says Pete Valenti, Hologic’s division president of breast and skeletal health solutions. “The 3Dimensions system represents a major breakthrough in breast cancer screening technology because it offers unprecedented image clarity regardless of breast size or density, increased comfort, and the reliable accuracy our customers have come to expect from Hologic products. We’re proud to introduce this new product, which serves as yet another example of why Hologic is the partner of choice for clinicians globally.”

The new Clarity HD high-resolution 3D imaging technology provides fast, high-resolution 3D images to accelerate screening and analysis, and is designed to clearly reveal subtle lesions and fine calcifications to help pinpoint cancers early. Clarity HD technology’s advanced detector and innovative 3D imaging algorithm work together to deliver high quality 3D images, regardless of breast size or density.

Intelligent 2D imaging technology works with Clarity HD technology to deliver overall image quality, and clarity, contrast, and detail at a lower dose.4

“Our experience as a leader in breast cancer screening has taught us that radiologists and technologists value accuracy above all else,” says Tracy Accardi, Hologic’s global vice president of research and development for breast and skeletal health solutions. “We developed the 3Dimensions system with that in mind, while adding two features that have great potential to improve patient satisfaction.”

One of these features, the SmartCurve breast stabilization system, is clinically proven to deliver a more comfortable mammogram without compromising image quality, workflow or dose. The SmartCurve system has been proven to improve comfort in 93 percent of women who reported moderate to severe discomfort with standard compression. It features a curved compression surface that mirrors the shape of a woman’s breast to reduce pinching and allow uniform compression over the entire breast.

In addition, Quantra 2.2 breast density assessment software, also available on the 3Dimensions system, enables clinicians to provide women with consistent breast density assessments during routine breast cancer screenings. Through a proprietary algorithm powered by machine learning, Quantra software analyzes mammography images for distribution and texture of breast tissue, delivering clinicians accurate breast density assessment. Quantra software categorizes breasts into four density categories, in alignment with the ACR BI-RADS® Atlas 5th Edition.